GTM
Earnings in 8 days · May 11, 2026 · After close
Signal
Mixed
Price
1
Move-0.68%Quiet session
Volume
1
Volume1.2× avgNormal activity
PRICE
Prev Close
5.85
Open
5.96
Day Range5.73 – 6.16
5.73
6.16
52W Range5.57 – 12.51
5.57
12.51
4% of range
VOLUME & SIZE
Avg Volume
9.4M
FUNDAMENTALS
P/E Ratio
15.3x
EPS (TTM)
Div Yield
No dividend
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
revenue +3% YoY · 84% gross margin
Valuation
FAIR
P/E 15x vs ~20x sector
Health
MODERATE
CR 0.7 (low) · FCF $1.21/sh
Bullish
Key MetricsTTM
Market Cap$2.03B
Revenue TTM$1.25B
Net Income TTM$124.20M
Free Cash Flow$388.80M
Gross Margin84.4%
Net Margin9.9%
Operating Margin20.1%
Return on Equity8.0%
Return on Assets1.9%
Debt / Equity1.20
Current Ratio0.72
EPS TTM$0.39

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
1 strong1 watch4 concern
31/100
Liquidity
0.72Concern
Leverage
1.20Watch
Coverage
5.9xStrong
ROE
8.0%Concern
ROIC
2.8%Concern
Cash
$176MConcern
ANALYST COVERAGE21 analysts
HOLD
+54.9%upside to target
L $6.00
Med $9.00consensus
H $12.00
Buy
733%
Hold
1048%
Sell
419%
7 Buy (33%)10 Hold (48%)4 Sell (19%)
Full report →
Stock Health
Composite Score
1 of 3 signals bullish
5/10
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusHold
~
LiquidityCurrent Ratio 0.72 — liquidity risk

2 signals unavailable — limited data for this stock

Upcoming Events
EEarnings ReportMay 4, 2026
Tomorrow
DEx-Dividend DateJul 31, 2026
In 89 days
PDividend PaymentAug 15, 2026
In 104 days
Technicals
Market Position
Price Levels
52W High
$12.51+115.3%
Current
$5.81
52W Low
$5.57-4.2%
52-Week RangeNear 52-week low
$5.574th %ile$12.51
Earnings & Analysts

ANALYST ESTIMATES

Consensus of 16 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2024
$1.2B
$1.2B$1.2B
$0.93
±2%
High15
FY2025
$1.2B
$1.2B$1.3B
+3.1%$1.05+12.4%
±1%
High16
FY2026(current)
$1.3B
$1.2B$1.3B
+1.5%$1.11+6.2%
±2%
High16
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryGTM
Last 8Q
+2.0%avg beat
Beat 6 of 8 quartersMissed 2 Estimates falling
+8%
Q2'24
-29%
Q3'24
+27%
Q4'24
+13%
Q1'25
-32%
Q2'25
+9%
Q3'25
+6%
Q4'25
+14%
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →
Neutral — mixed activity
90d01
CitigroupNeutral → Underperform
Feb 10
DOWNGRADE
KeyBancUnderweight → Sector Weight
Dec 15
UPGRADE
Wells FargoBuy → Underweight
Jun 13
DOWNGRADE
KeyBancSector Weight → Underweight
Dec 12
DOWNGRADE
DaiwaNeutral
Aug 13
DOWNGRADE
KeyBancOverweight → Sector Weight
Aug 6
DOWNGRADE
Raymond JamesOutperform → Market Perform
Aug 6
DOWNGRADE
CitigroupSell
Feb 8
DOWNGRADE
RBC CapitalOutperform → Sector Perform
Jul 24
DOWNGRADE
UBSBuy → Neutral
Feb 7
DOWNGRADE
Insider Activity
SEC Filings →
0 Buys/4 SellsNet Selling
Mcgrane AshleyGeneral Counse…
$41K
Apr 2
SELL
Roth James MChief Revenue …
$210K
Apr 2
SELL
Mcgrane AshleyGeneral Counse…
$12K
Mar 13
SELL
Roth James MChief Revenue …
$300K
Feb 18
SELL
Financials
News & Activity

GTM News

20 articles · 4h ago

About

No company information available